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Background: The purpose of this study was to evaluate the efficacy and safety of a new 
  instrument to optimize the size, shape, and centration of anterior capsulorhexis.
Methods: The study was divided into two parts. The first part was done in 10 goats’ eyes. A 
specially designed capsulorhexis marker was used. The lower edge of the instrument was stained 
by gentian violet and then applied to the anterior capsule to produce a circular mark of 5.5 mm. 
In five eyes, the gentian violet was applied to the marker using a corneal marking pen; in the 
remaining five eyes, the gentian violet was applied using a corneal marking pad. In the second 
part, the toxicity of gentian violet was tested as follows: ten albino rabbits received a gentian 
violet injection into the anterior chamber in one eye (experimental group) and an equal volume 
of balanced salt solution in the fellow eye (control group). Five rabbits were sacrificed one day 
after surgery and the remaining five rabbits after one week.
Results: In the first part, there was no difficulty in the introduction or removal of the instrument 
from all eyes. In the first two eyes, the circular mark was diffuse due to sliding of the marker 
on the surface of the anterior capsule. In the remaining eight eyes, there was a well-centered, 
rounded mark which was adequately stained. In the second part, there was no histopathological 
evidence of corneal toxicity in either group. There was loss of ganglion cells from the neuro-
sensory retina one day after surgery in one eye from the experimental group. At one week, there 
was no evidence of retinal toxicity in any of the rabbits.
Conclusion: This capsulorhexis marker can guide the surgeon to a better centration and proper 
sizing of anterior capsulorhexis using gentian violet staining. More refinement of the instrument 
is needed to be able to use it in human eyes.
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Introduction
With the introduction of phacoemulsification as standard cataract surgery, anterior 
capsulorhexis has become an essential step. Anterior capsulorhexis can be performed 
using a 26-gauge needle or capsulorhexis forceps.1,2 However, when performed 
  free-hand, it is not always easy to create a perfectly sized anterior capsulorhexis that 
is also perfectly centered relative to the pupil or the limbus. Although the anterior 
capsulorhexis obtained is usually continuous, it may still be noncurvilinear, varying 
from kidney-shaped to heart-shaped, and in some cases it may be discontinuous.3 
Moreover, the introduction of multifocal intraocular lenses has increased the need for 
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Many investigators have attempted to design new tools 
for better control of the size and shape of the capsulorhexis, 
such as diathermy rhexis4 and vitrectorhexis.5 Certain styles 
of capsule forceps have also been designed with laser marks 
to help surgeons produce various capsulotomy diameters. 
However, these forceps are limited in their ability to provide 
a diameter reference in the horizontal meridian parallel to 
the phacoemulsification incision.6
The aim of this study was to evaluate the efficacy and safety 
of a new instrument to optimize the size, shape, and centra-
tion of anterior capsulorhexis during   phacoemulsification by 
making a circular mark on the anterior capsule using gentian 
violet stain.
Materials and methods
This study was divided into two parts. The first part was 
performed in a fully equipped wet laboratory (Alcon 
  Laboratories, Cairo, Egypt) where goats’ eyes were used. The 
second part was done at Cairo University Medical School 
animal house facility using albino rabbits. We adhered to the 
tenets of the National Institutes of Health statement on the 
use of animals in research.
Use of capsulorhexis marker  
to stain the anterior capsule
A stainless steel capsulorhexis marker was specially designed 
for this study. It was formed of a handle attached to a ring with 
an inner diameter of 5.5 mm and a height of 1 mm (Figure 1). 
Ten goats’ eyes were prepared for the procedure. A 3 mm cor-
neal tunnel was performed in each eye followed by injection 
of viscoelastic material into the anterior chamber. The wound 
was then widened to 6 mm to allow easy introduction of the 
instrument. In five eyes, the lower edge of the ring was stained 
by gentian violet using a surgical marking pen (Viscot Medical, 
East Hanover, NJ) whereas in the other five eyes, the lower edge 
of the ring was stained by gentian violet using a surgical marker 
pad (Vismark®, Viscot Medical). The capsulorhexis marker was 
introduced into the anterior   chamber and the ring was centered 
within the   papillary area. The lower edge of the ring was applied 
onto the anterior capsule for a few seconds without pressure to 
avoid zonular stress. The marker was then removed from the eye 
and assessment of the mark was done as regards centration and 
degree of staining of the anterior capsule (Figure 2).
Assessment of intraocular toxicity
Because we were using a preparation of gentian violet 
designed for extraocular use (on the corneal surface), we 
needed to assess the intraocular toxicity in an animal model. 
Accordingly, 10 albino rabbits weighing 2–4 kg received a 
gentian violet injection into the anterior chamber in one eye 
(experimental group), and an equal volume of balanced salt 
solution in the fellow eye (control group).
surgical technique
The rabbits were anesthetized with an intramuscular injection 
of xylazine 5–8 mg/kg and ketamine hydrochloride 35–44 mg/
kg. The pupils were dilated with tropicamide and phenyleph-
rine 10% eye drops. In the experimental group, the lower edge 
of the ring was stained by gentian violet using the surgical 
marking pen. The ring was then left in the well of a sterile 
contact lens case containing balanced salt solution 0.1 mL 
for two minutes. The stained balanced salt solution was then 
injected into the anterior chamber using a 27-gauge needle. In 
the control group, balanced salt solution 0.1 mL was injected 
5.5 mm
1 mm
Figure 1 Diagrammatic representation of capsulorhexis marker. Figure 2 Capsulorhexis mark on the anterior capsule.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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into the anterior chamber using a 27-gauge needle. All animals 
were kept in the animal house and were handled according to 
the Association for Research in Vision and Ophthalmology 
statement on use of animals in   ophthalmic and vision research. 
Five rabbits were sacrificed one day after surgery and the 
remaining five after one week. The eye balls were enucleated 
and immediately fixed in Bouin’s solution, dehydrated in 
ascending grades of alcohol (70%, 90%, and 100%), cleared 
in xylol, and embedded in paraffin. The embedded specimens 
were then sectioned (5–7 µm thickness), stained with hema-
toxylin and eosin, and examined by light microscopy.
Results
Use of capsulorhexis marker to stain 
anterior capsule
There was no difficulty in the introduction or removal of the 
instrument from any of the eyes. There was no difference in 
the degree of capsular staining using either the marker pen or 
the marker pad. In the first two eyes, the mark was not clear 
due to sliding of the ring on the surface of the anterior capsule; 
this resulted in spread of the stain, leading to a diffuse mark. In 
all other cases, care was taken not to touch the anterior capsule 
during introduction of the instrument into the anterior chamber. 
Once in place, the ring was pressed down on the anterior capsule 
without undue sliding. This resulted in a well-centered rounded 
mark which was adequately stained, precise, and clear enough 
to guide the surgeon to perform a 5.5 mm capsulorhexis.
Assessment of intraocular toxicity
Histopathologically, none of the eyes in the study or control 
group showed any sign of corneal toxicity at one day and one 
Figure  3 Photomicrograph  of  a  control  rabbit  cornea  showing  flat  endothelial 
cells with flat nuclei (thick arrow) resting on Descemet’s membrane (thin arrow). 
Hematoxylin and eosin staining, 400×.
Figure 4 Photomicrograph of an experimental rabbit’s cornea showing normally 
appearing flat endothelial cells (thick arrow) and intact Descemet’s membrane (thin 
arrow). Hematoxylin and eosin staining, 400×.
week after surgery (Figures 3 and 4). Light microscopy exam-
ination of multiple sections from each eye showed   normal 
iris tissue, ciliary body epithelium, and lens   epithelium. The 
retina was normal in all eyes of the control group at one day 
and one week after the surgery (Figure 5). In the experimental 
group, there was no evidence of retinal toxicity at one day 
and one week after surgery with the exception of one eye 
that showed evidence of loss of ganglion cells from the neu-
rosensory retina one day after surgery (Figure 6).
Discussion
A well constructed capsulorhexis is the foundation of 
  complication-free phacoemulsification and intraocular lens 
surgery. Ophthalmic surgical dyes have become valuable tools, 
and are now widely used in both anterior and posterior segment 
Figure  5  Photomicrograph  of  a  section  in  a  control  rabbit’s  retina  showing 
photoreceptors layer (1), outer nuclear layer (2), outer reticular layer (3), inner 
nuclear layer (4), inner reticular layer (5), and ganglion cell layer (6). Hematoxylin 
and eosin staining, 400×.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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indications. In this study, we present a preliminary prototype 
of a capsulorhexis marker which is first stained by gentian 
violet and then applied directly onto the anterior capsule in 
order to make a rounded mark to guide the surgeon to a better 
centering and proper sizing of the rhexis. Moreover, it may 
help phacoemulsification beginners and shorten their learning 
curve for this crucial step in modern cataract surgery.
Today’s demanding refractive results require a well-
  centered, perfectly circular capsulorhexis that slightly over-
laps the intraocular lens optic. This construction is important 
for achieving the so-called capsular “shrink-wrap” effect 
during the postoperative period. A 360° overlapping capsular 
edge creates a capsular bend, which acts as a barrier against 
proliferating lens epithelial cells and thus significantly delays 
the onset of posterior capsular opacification.7–9 This overlap 
also sets the anteroposterior positioning of the intraocular 
lens, which prevents capsular fibrosis from shifting the 
lens optic forward and creating an unwanted late refractive 
shift. Moreover, with a perfectly circular capsulorhexis, 
any contraction of the anterior capsule (ie, phimosis) will 
be symmetrical, so late in-the-bag decentering of the optic 
is prevented.10 Also, if the capsulorhexis is too small, it can 
result in glare, halos, and night driving problems with a 
diffractive multifocal intraocular lens. Capsular phimosis 
is more pronounced with small capsulotomies.11,12 A small 
capsular opening makes surgery more difficult and places 
greater stress on the anterior capsule during nuclear division 
or quadrant removal. Furthermore, a smaller capsular open-
ing can obscure peripheral retinal visibility and treatment. 
A capsulorhexis with a 5.5 mm diameter is usually ideal.
Many investigators have tried to improve the predictabil-
ity of size, shape, and centration of capsulorhexis. Wallace6 
performed a study to make a central corneal mark with a 
6.0 mm optical zone marker, previously used for radial kera-
totomy (with the center of the optical zone as the central visual 
axis), as the patient fixates on the light of the   microscope. 
He performed the capsulorhexis in the usual way with the 
intention of leaving the borders of the capsulotomy inside 
the capsulotomy diameter mark. However, this technique has 
some disadvantages. First, because corneal curvatures are 
not uniform between patients, a different mark size would be 
required for each patient to achieve the correct capsulorhexis 
size. Moreover, use of this marker incorrectly implies that 
corneal curvature remains constant after the incisions are 
made.3 Finally, the corneal plane and the anterior capsule 
plane must be parallel with the focal plane of the operating 
microscope to avoid parallax errors, and the surgeon may 
confuse the corneal mark with the anterior capsule rim at 
the time of intraocular lens implantation.13
Tassignon et al3 designed a 0.25 mm ring-shaped caliper 
with an internal diameter of 5.0 mm or 6.0 mm. After its inser-
tion, the ring is gently pushed on top of the anterior capsule 
with additional Healon GV . A small opening is made in the 
center of the capsule. The surgeon then carefully follows the 
internal border of the ring caliper. However, this technique is 
not precise because the ring is not fixed on the anterior surface 
of the capsule, and thus any movement of the ring will affect 
the size, shape, and centration of the capsulorhexis.
A promising technological solution involves overlaying a 
reference ring on the surgeon’s view through the microscope. 
Carl Zeiss Meditec Inc developed an interface module that 
adjusts the size of the ring appropriately with microscope 
magnification while keeping it centered within the limbus 
using real-time eye tracking.14 Moreover, several companies 
are developing femtosecond technologies to perform the 
capsulorhexis.
To our knowledge, this is the first published article in 
the literature describing an instrument that makes a circular 
mark on the anterior capsule using a stain. Gentian violet 
(hexamethyl rosaniline chloride) is a triphenylmethane 
(rosaniline) dye. The pure compound is known as crystal 
violet. It was chosen for this study because it is cheap, eas-
ily available, and intensely and homogeneously stains the 
anterior capsule.15
Different techniques have been proposed for staining of 
the anterior capsule by different dyes. Many surgeons con-
tinue to inject capsular dye beneath an air bubble, as originally 
Figure 6 A photomicrograph of a section in an experimental rabbit’s retina showing 
a ganglion cell with pyknotic (dark) nucleus (thick arrow) and another one (thin 
arrow) that is displaced within the inner reticular layer (IRL). Hematoxylin and eosin 
staining, 400×.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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described by Horiguchi et al16 and Melles et al.17 Laureano 
and Coroneo18 suggested simply omitting the air bubble. 
Kayikicioglu et al19 have used a viscoelastic-mixing tech-
nique with 0.4% trypan blue. In this study, we applied the 
dye directly onto the anterior surface of the capsule by the 
lower edge of the capsulorhexis marker and this helped in 
decreasing the amount of the dye inserted into the anterior 
chamber and also in avoiding inadvertent application of the 
dye towards the corneal endothelium.
Many studies have investigated the ocular toxicity of gentian 
violet. Previously, gentian violet 0.1% with methylene blue 1% 
was used for staining.17 This combination is no longer used 
because the endothelial toxicity of the dyes causes corneal 
edema. Ünlü et al15 examined the effects of gentian violet 0.001% 
and gentian violet 0.01% without methylene blue and found that 
each concentration of gentian violet alone was effective in stain-
ing the anterior capsules of white cataracts and found that both 
concentrations had no toxic effects on intraocular tissues. Gamal 
Eldin et al20 reported that gentian violet 0.05%–2% stained the 
anterior capsule of the rabbit eye effectively, but that only the 
lowest concentration (0.05%) showed excellent preservation of 
the cornea during one week of observation. In the second part of 
our study, we studied the toxicity of gentian violet derived from 
the marker pen. This pen is generally used to make an external 
mark on the outer surface of the cornea during keratoplasty and 
keratorefractive procedures. No toxic changes were evident in 
the cornea, iris tissue, ciliary body epithelium, or in the lens 
epithelium. Only one eye had partial ganglion cell loss from the 
retina one day after surgery. This may represent a preparation 
artifact rather than a true toxic effect.
In this study, we used a simple preliminary prototype that 
needs a large corneal incision (6 mm) to be introduced inside 
the eye. We considered this as the first step in our research 
and we are looking forward to changing the material of the 
marker in order to form a memory ring that is able to be 
introduced and removed from the eye through a small inci-
sion and become ergonomically feasible. However, it can be 
used as such in cases of combined cataract extraction with 
penetrating keratoplasty because there is enough room to 
introduce the instrument after trephination of the recipient 
cornea. An important issue to be addressed is the proper way 
to centralize the marker on the surface of the anterior capsule 
in relation to the visual axis.
Conclusion
This capsulorehxis marker is an instrument designed to 
optimize the size, shape, and centering of the capsulorhexis 
during phacoemulsification by impressing a circular pattern 
on the anterior capsule to guide the surgeon in creating a 
5.5–6.0 mm diameter capsulorhexis. More refinement of the 
instrument is needed to be able to use it in human eyes.
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